LivaNova Plc (LIVN)
64.70
-0.56
(-0.86%)
USD |
NASDAQ |
Mar 05, 16:00
64.70
0.00 (0.00%)
After-Hours: 20:00
LivaNova Research and Development Expense (Annual) : 182.16M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| NovoCure Ltd. | 224.54M |
| Alphatec Holdings, Inc. | 76.27M |
| AtriCure, Inc. | 90.17M |
| ResMed, Inc. | 331.28M |
| iRhythm Holdings, Inc. | 84.61M |